769 A single dose of intratumoral TransCon™ TLR7/8 agonist monotherapy promoted sustained activation of antigen presenting cells resulting in CD4+ and CD8+ T cell activation and tumor growth inhibition

Authors: Amer Mirza, David Rosen, Juha Punnonen, Enping Hong, Luis Zuniga, Karan Uppal, Kathy Bang, Simran Sabharwal, Yuchi Lee, Solomon Martinez

Source: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/2213c1af161a460dae21110d56f96d23